These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37065)

  • 1. Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.
    McDevitt DG
    Drugs; 1979 Apr; 17(4):267-88. PubMed ID: 37065
    [No Abstract]   [Full Text] [Related]  

  • 2. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.
    van Zwieten PA
    Drugs; 1993 Apr; 45(4):509-17. PubMed ID: 7684671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of adrenoceptor blockers in the treatment of hypertension].
    Mikami H; Ogihara T
    Nihon Rinsho; 1989 Sep; 47(9):2035-40. PubMed ID: 2574242
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proxodolol--a new beta- and alpha-adrenoblockader].
    Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
    Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic blocking agents.
    Kendall MJ; Smith SR
    J Clin Hosp Pharm; 1983 Jun; 8(2):155-73. PubMed ID: 6135714
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
    Blakeley AG; Summers RJ
    Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of proxodolol on systemic and regional hemodynamics].
    Dolgun OV; Martynova ER; Medvedev OS; Iuzhakov SD
    Eksp Klin Farmakol; 1994; 57(3):33-6. PubMed ID: 7914116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective effect of alpha beta-blockers on hypertensive target-organ damage].
    Kai H; Imaizumi T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():587-90. PubMed ID: 15171441
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alpha beta-blockers for patients with hypertension].
    Mizuta Y; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():305-9. PubMed ID: 16981560
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
    Pandhi P; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circadian rise of blood pressure and combined alpha-beta adrenoceptor blockade].
    Rietbrock N; Woodcock BG
    Dtsch Med Wochenschr; 1985 Mar; 110(10):388-91. PubMed ID: 2857634
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol.
    Brizzi A; Brizzi V; Valoti M
    Farmaco; 2005 Feb; 60(2):105-11. PubMed ID: 15752469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined alpha- and beta-adrenergic blockade in the treatment of hypertension: myth or reality? Workshop held in Corsendonck (Belgium) on February 28, 1981.
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S1-74. PubMed ID: 6169955
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of adrenoceptor-blocking drugs on plasma lipoprotein concentrations.
    Miller NE
    Am J Cardiol; 1987 Sep; 60(9):17E-23E. PubMed ID: 2889350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.